Assenagon Asset Management
OM icon

Assenagon Asset Management’s Outset Medical OM Stock Holding History

Assenagon Asset Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Sell
339,438
-164,655
-33% -$720K ﹤0.01% 905
2026
Q1 		$1.94M Sell
504,093
-4,321
-0.8% -$17.7K ﹤0.01% 781
2025
Q4 		$1.89M Buy
508,414
+131,381
+35% +$1.13M ﹤0.01% 836
2025
Q3 		$5.32M Buy
+377,033
New +$5.88M 0.01% 609
2025
Q1 		– Sell
-19,319
Closed -$322K – 1292
2024
Q4 		$322K Sell
19,319
-7,189
-27% -$89.7K ﹤0.01% 1240
2024
Q3 		$269K Sell
26,508
-74,500
-74% -$2.22M ﹤0.01% 1307
2024
Q2 		$5.83M Buy
101,008
+38,018
+60% +$1.86M 0.01% 584
2024
Q1 		$2.1M Sell
62,990
-5,068
-7% -$257K 0.01% 879
2023
Q4 		$5.52M Buy
68,058
+26,351
+63% +$2.14M 0.01% 604
2023
Q3 		$6.81M Buy
+41,707
New +$9.84M 0.02% 495
2023
Q1 		– Sell
-6,575
Closed -$2.55M – 1479
2022
Q4 		$2.55M Hold
6,575
– – 0.01% 729
2022
Q3 		$1.57M Hold
6,575
– – 0.01% 782
2022
Q2 		$1.47M Buy
6,575
+6,240
+1,863% +$2.68M 0.01% 955
2022
Q1 		$228K Sell
335
-1,792
-84% -$1.08M ﹤0.01% 1337
2021
Q4 		$1.47M Sell
2,127
-1,711
-45% -$1.27M ﹤0.01% 933
2021
Q3 		$2.85M Sell
3,838
-1,406
-27% -$958K 0.01% 590
2021
Q2 		$3.93M Buy
+5,244
New +$4.01M 0.01% 537

Other funds holding OM

MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return

Assenagon Asset Management's OM Position: Q2 2026 in Review

Assenagon Asset Management reduced its Outset Medical (OM) stake by 33% in Q2 2026, selling an estimated $720K and leaving 339,438 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #905.

Assenagon Asset Management first reported a position in OM in Q2 2021 and has held it in 17 quarters since. The position peaked at $6.81M in Q3 2023. 7 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Assenagon Asset Management held 339,438 shares of Outset Medical worth $1.47M as of Q2 2026.
  • Assenagon Asset Management sold 164,655 Outset Medical shares in Q2 2026, an estimated $720K.
  • Outset Medical made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #905 holding.
  • Assenagon Asset Management first reported a position in Outset Medical in Q2 2021 and has held it in 17 quarters since.
  • Assenagon Asset Management's Outset Medical position peaked at $6.81M in Q3 2023.
  • 7 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.